Intec Parent Inc. (NTEC) NASDAQ CAPITAL MARKET

$9.63 - (-)

Market Cap: $70.98M

As of 08/03/21 12:00 AM EDT. Market closed.

(NTEC)

Intec Parent Inc. (NTEC)
NASDAQ CAPITAL MARKET

$9.63
- (-)

Market Cap: $70.98M

As of 08/03/21 12:00 AM EDT. Market closed.

Add to Portfolio

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release ... read more

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jeffrey Meckler
Full Time Employees
40
URL
Address
12 Hartom Street, Jerusalem, Har Hotzvim, 777512.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jeffrey Meckler
Full Time Employees
40
Address
12 Hartom Street, Jerusalem, Har Hotzvim, 777512.
PRICE CHART FOR INTEC PARENT INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.81
Previous Close
$9.63
Days Range
$9.59 - $11.10
52 week range
$8.80 - $36.80
Volume
0
Avg. Volume (30 days)
2,095,733
Market Cap
$70.98M
Dividend Yield
-
P/E
-
Shares Outstanding
7,370,883
Open
$9.81
Previous Close
$9.63
Days Range
$9.59 - $11.10
52 week range
$8.80 - $36.80
Volume
0
Avg. Volume (30 days)
2,095,733
Market Cap
$70.98M
Dividend Yield
-
P/E
-
Shares Outstanding
7,370,883
FINANCIAL STATEMENTS FOR INTEC PARENT INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INTEC PARENT INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Dexcel Pharma Technologies Ltd.10% OwnerJan 31, 2020 Sale$0.31725,951224,3194,424,897Feb 04, 2020, 06:41 PM
Dexcel Pharma Technologies Ltd.10% OwnerFeb 04, 2020 Sale$0.29110,00031,9004,234,897Feb 04, 2020, 06:41 PM
Dexcel Pharma Technologies Ltd.10% OwnerFeb 03, 2020 Sale$0.3280,00025,4404,344,897Feb 04, 2020, 06:41 PM
Silberman IssacDirectorNov 19, 2019 Sale$0.501,0005044,000Nov 21, 2019, 05:00 PM
Meckler Jeffrey AChief Executive OfficerAug 28, 2019 Buy$0.6820,00013,620196,761Aug 29, 2019, 04:16 PM
MADDALUNA ANTHONY JDirectorAug 27, 2019 Buy$0.4725,00011,75053,570Aug 29, 2019, 04:16 PM
KOZARICH JOHN WDirectorAug 23, 2019 Buy$0.46100,00045,900151,761Aug 27, 2019, 04:20 PM
Meckler Jeffrey AChief Executive OfficerAug 23, 2019 Buy$0.46100,00045,700176,761Aug 27, 2019, 04:18 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Dexcel Pharma Technologies Ltd.10% Owner01/31/2020224,319
Dexcel Pharma Technologies Ltd.10% Owner02/04/202031,900
Dexcel Pharma Technologies Ltd.10% Owner02/03/202025,440
Silberman IssacDirector11/19/2019504
Meckler Jeffrey AChief Executive Officer08/28/201913,620
MADDALUNA ANTHONY JDirector08/27/201911,750
KOZARICH JOHN WDirector08/23/201945,900
Meckler Jeffrey AChief Executive Officer08/23/201945,700
BUYBACK ANNOUNCEMENT(S) FOR INTEC PARENT INC
LOADING...